Skip to main content

Site Search

Choose Location

Americas
Asia Pacific
Europe
International
Middle East & Africa

: Argentina | Español
: Brazil | Português
: Canada | English
: Canada | Français
: Central America | Español
: Colombia | Español
: Mexico | Español
: United States | English

: Australia | English
: Bangladesh | English
: Hong Kong S.A.R. | 繁體中文
: India | English
: Indonesia | English
: Japan | 日本語
: Korea | 한국어
: Mainland China | 中文
: Malaysia | English
: Pakistan | English
: Philippines | English
: Singapore | English
: Taiwan | 繁體中文
: Thailand | ภาษาไทย

: Austria | Deutsch
: Belgium | Français
: Belgium | Nederlands
: Bulgaria | Български
: Czech Republic | Česky
: Czech Republic | English
: Denmark | Dansk
: Estonia | Eesti
: Finland | Suomalainen
: France | Français
: Germany | Deutsch
: Greece | Ελληνικά
: Hungary | Magyar
: Ireland | English
: Italy | Italiano
: Latvia | Latvian
: Lithuania | Lithuanian
: Netherlands | Nederlands
: Norway | Norsk
: Poland | Polski
: Portugal | Português
: Romania | Română
: Russia | Русский
: Serbia | Srpski
: Slovakia | Slovensky
: Slovenia | Slovenščina
: Slovenia | English
: Spain | Español
: Sweden | Svenska
: Switzerland | Deutsch
: Switzerland | Français
: Türkiye | Türkçe
: United Kingdom | English

: Global | English
: Novartis Foundation | English

: Egypt | English
: Israel | עברית
: Saudi Arabia | العربية
: South Africa | English

Choose Location

Americas Asia Pacific Europe International Middle East & Africa

: Argentina | Español
: Australia | English
: Austria | Deutsch
: Bangladesh | English
: Belgium | Français
: Belgium | Nederlands
: Brazil | Português
: Bulgaria | Български
: Canada | English
: Canada | Français
: Central America | Español
: Colombia | Español
: Czech Republic | Česky
: Czech Republic | English
: Denmark | Dansk
: Egypt | English
: Estonia | Eesti
: Finland | Suomalainen
: France | Français
: Germany | Deutsch
: Greece | Ελληνικά
: Hong Kong S.A.R. | 繁體中文
: Hungary | Magyar
: India | English
: Indonesia | English
: Ireland | English
: Israel | עברית
: Italy | Italiano
: Japan | 日本語
: Korea | 한국어
: Latvia | Latvian
: Lithuania | Lithuanian
: Mainland China | 中文
: Malaysia | English
: Mexico | Español
: Netherlands | Nederlands
: Norway | Norsk
: Global | English
: Novartis Foundation | English
: Pakistan | English
: Philippines | English
: Poland | Polski
: Portugal | Português
: Romania | Română
: Russia | Русский
: Saudi Arabia | العربية
: Serbia | Srpski
: Singapore | English
: Slovakia | Slovensky
: Slovenia | Slovenščina
: Slovenia | English
: South Africa | English
: Spain | Español
: Sweden | Svenska
: Switzerland | Deutsch
: Switzerland | Français
: Taiwan | 繁體中文
: Thailand | ภาษาไทย
: Türkiye | Türkçe
: United Kingdom | English
: United States | English

About

Novartis in Philippines

Strategy

Diversity and Inclusion

People and Culture

Products

Country Leadership Team

Contact

About

Patients and Caregivers

Novartis Commitment to Patients and Caregivers

Diseases

Patient resources

Products

Adverse Event Reporting

Patients and Caregivers

Healthcare Professionals

Healthcare professional country resource

Products

Novartis Pipeline

Adverse Event Reporting

Novartis Clinical Trials

Healthcare Professionals

ESG

Financial Transparency for Philippines

Ethical Behavior

Code of Ethics

SpeakUp

Ethics, Risk and Compliance

Access

Environmental Sustainability

Global Health

ESG

News

News Archive

Stories

Contacts

News

Careers

Career Search

Meet the teams

Early Talent

How We Work

Diversity and Inclusion

Career Programs

Awards and Recognition

Careers

Coronavirus

Coronavirus
Home

What is PIK3CA and why is it important to you?

Back to previous page

What is PIK3CA and why is it important to you?

Description

A leaflet informing about the PIK3CA mutation and why does it occur in breast cancer.

Download (PDF 1.99 MB)

Related Items

Document

lock

Breast Cancer

Improving Breast Cancer Survivorship in the Philippines: Policy and Program Implications from The Pink Initiative
PDF

lock

Breast Cancer

2024 PNCS Novartis Symposium
Video

lock

Breast Cancer

See What Lies Beneath Breast Cancer - Video
Document

lock

Breast Cancer

Hindi Pare-pareho ang mga uri ng kanser sa suso

Novartis Philippines

Navigate Novartis

Patients & Caregivers
Healthcare Professionals
ESG
News
Careers

Media Center

News Archive
Stories

Our Portfolio

Novartis Clinical Pipeline
Novartis Product Portfolio

NPC Seal of Registration

Footer Site Search

Footer Bottom

© 2025 Novartis AG

Privacy Policy
Terms of Use
Cookie Settings
Site Map
Web Accessibility

Novartis Site Directory

This site is intended for an audience in the Philippines